These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36271842)

  • 1. Fasting intervention and its clinical effects on the human host and microbiome.
    Forslund SK
    J Intern Med; 2023 Feb; 293(2):166-183. PubMed ID: 36271842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Fiber, Gut Microbiota, and Metabolic Regulation-Current Status in Human Randomized Trials.
    Myhrstad MCW; Tunsjø H; Charnock C; Telle-Hansen VH
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32210176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota and Metabolic Disorders: Advances in Therapeutic Interventions.
    Akash MSH; Fiayyaz F; Rehman K; Sabir S; Rasool MH
    Crit Rev Immunol; 2019; 39(4):223-237. PubMed ID: 32421966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes.
    Houghton D; Hardy T; Stewart C; Errington L; Day CP; Trenell MI; Avery L
    Diabetologia; 2018 Aug; 61(8):1700-1711. PubMed ID: 29754286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota as a Target in the Pathogenesis of Metabolic Disorders: A New Approach to Novel Therapeutic Agents.
    Ejtahed HS; Soroush AR; Angoorani P; Larijani B; Hasani-Ranjbar S
    Horm Metab Res; 2016 Jun; 48(6):349-58. PubMed ID: 27203411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Dietary Fibre in Modulating Gut Microbiota Dysbiosis in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    Ojo O; Feng QQ; Ojo OO; Wang XH
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33113929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary restrictions modulate the gut microbiota: Implications for health and disease.
    Schmidt NS; Lorentz A
    Nutr Res; 2021 May; 89():10-22. PubMed ID: 33878569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micronutrients impact the gut microbiota and blood glucose.
    Barra NG; Anhê FF; Cavallari JF; Singh AM; Chan DY; Schertzer JD
    J Endocrinol; 2021 Jul; 250(2):R1-R21. PubMed ID: 34165440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the gut microbiota in type 2 diabetes and related diseases.
    Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
    Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.
    Remely M; Aumueller E; Merold C; Dworzak S; Hippe B; Zanner J; Pointner A; Brath H; Haslberger AG
    Gene; 2014 Mar; 537(1):85-92. PubMed ID: 24325907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs.
    Palmnäs-Bédard MSA; Costabile G; Vetrani C; Åberg S; Hjalmarsson Y; Dicksved J; Riccardi G; Landberg R
    Am J Clin Nutr; 2022 Oct; 116(4):862-874. PubMed ID: 36026526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in human gut microbiota composition are linked to the energy metabolic switch during 10 d of Buchinger fasting.
    Mesnage R; Grundler F; Schwiertz A; Le Maho Y; Wilhelmi de Toledo F
    J Nutr Sci; 2019; 8():e36. PubMed ID: 31798864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyromonas gingivalis induces entero-hepatic metabolic derangements with alteration of gut microbiota in a type 2 diabetes mouse model.
    Kashiwagi Y; Aburaya S; Sugiyama N; Narukawa Y; Sakamoto Y; Takahashi M; Uemura H; Yamashita R; Tominaga S; Hayashi S; Nozaki T; Yamada S; Izumi Y; Kashiwagi A; Bamba T; Ishihama Y; Murakami S
    Sci Rep; 2021 Sep; 11(1):18398. PubMed ID: 34526589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fat and not sugar as the determining factor for gut microbiota changes, obesity, and related metabolic disorders in mice.
    Suriano F; Vieira-Silva S; Falony G; de Wouters d'Oplinter A; Paone P; Delzenne NM; Everard A; Raes J; Van Hul M; Cani PD
    Am J Physiol Endocrinol Metab; 2023 Jan; 324(1):E85-E96. PubMed ID: 36516223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

  • 19. Intermittent Fasting Improves Cardiometabolic Risk Factors and Alters Gut Microbiota in Metabolic Syndrome Patients.
    Guo Y; Luo S; Ye Y; Yin S; Fan J; Xia M
    J Clin Endocrinol Metab; 2021 Jan; 106(1):64-79. PubMed ID: 33017844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
    Diamant M; Blaak EE; de Vos WM
    Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.